- Trials with a EudraCT protocol (47)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
47 result(s) found for: Coagulant.
Displaying page 1 of 3.
EudraCT Number: 2021-001418-12 | Sponsor Protocol Number: NCT04483583 | Start Date*: 2021-06-24 |
Sponsor Name:University of Florida | ||
Full Title: Tailoring P2Y12 Inhibiting Therapy in Patients requiring Oral Anticoagulation after undergoing Percutaneous Coronary Intervention: The Switching Anti-Platelet and Anti-Coagulant Therapy – 2 Study | ||
Medical condition: Efficacy of antiplatelet therapy after percutaneous coronary intervention in patients using oral anticoagulants | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003232-80 | Sponsor Protocol Number: 2017-71 | Start Date*: 2019-03-04 |
Sponsor Name:ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE | ||
Full Title: RENACTIF: Reduction of the Thrombotic Phenotype in Renal Insufficiency With N-AcetylCysteine : A Randomized, Double-blind, Placebo-controlled, Cross-over Trial | ||
Medical condition: Chronic Kidney Disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-000388-41 | Sponsor Protocol Number: OZR-2013-27 | Start Date*: 2014-05-05 |
Sponsor Name:The Rotterdam Eye Hospital | ||
Full Title: Does oral administration of dabigatran etexilate, a direct thrombin inhibitor, achieve clinical significant concentrations of dabigatran and thrombin inhibiting activity in vitreous and subretinal ... | ||
Medical condition: Ocular accessibility of dabigatran in patients with retinal detachment | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-002562-40 | Sponsor Protocol Number: 16-021 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Portola Pharma UK Ltd | |||||||||||||
Full Title: A phase 1, open-label, single dose, non-randomized study to evaluate pharmacokinetics, pharmacodynamics, and safety of Betrixaban in pediatric patients. | |||||||||||||
Medical condition: Pediatric patients who are assessed to be at risk for Venous thromboembolism (VTE) but does not require immediate anticoagulant therapy, for example: a. Has previous thrombosis and completed a cour... | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001563-11 | Sponsor Protocol Number: GENA-01 | Start Date*: 2009-10-22 |
Sponsor Name:Octapharma AG | ||
Full Title: Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of human-cl rhFVIII, a Newly Developed Human Cell-Line Derived Recombinant FVIII Concentrate in Previously Tr... | ||
Medical condition: Severe hemophilia A (FVIII:C <1%) | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male | |
Trial protocol: DE (Completed) BG (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-000026-31 | Sponsor Protocol Number: ML18704 | Start Date*: 2006-06-20 |
Sponsor Name:Roche Austria GmbH | ||
Full Title: Bevacizumab as treatment for patients with relapsed/refractory multiple myeloma | ||
Medical condition: Multiple myeloma, relapsed/refractory after at least 2 lines of prior therapy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2006-003291-35 | Sponsor Protocol Number: ML 19884 | Start Date*: 2007-11-26 | |||||||||||
Sponsor Name:ROCHE | |||||||||||||
Full Title: Phase II, open label, neoadjuvant study of Bevacizumab in patients with inflammatory or locally advanced breast cancer | |||||||||||||
Medical condition: Patients with inflammatory or locally advanced operable breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001073-29 | Sponsor Protocol Number: FLD-VAT-2007-01 | Start Date*: 2008-09-19 | |||||||||||
Sponsor Name:Fernando Lago Deibe | |||||||||||||
Full Title: Ensayo clínico prospectivo, en fase IV, controlado, aleatorizado, doble ciego y en grupos paralelos para evaluar la efectividad y seguridad de la vacunación antitetánica en pacientes en tratamiento... | |||||||||||||
Medical condition: Comparación de la administración intramuscular y subcutánea de la vacuna Tétanos-Difteria Adultos en pacientes tratados con anticoagulantes orales. Comparison of the intramuscular and subcutaneo... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005963-29 | Sponsor Protocol Number: ERM62646-A | Start Date*: 2021-03-12 |
Sponsor Name:University of Melbourne | ||
Full Title: Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial | ||
Medical condition: COVID-19 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-005045-17 | Sponsor Protocol Number: 74983 | Start Date*: 2022-04-05 |
Sponsor Name:AMC | ||
Full Title: Resuscitation for repair of endothelial permeability in endotoxemia | ||
Medical condition: Acute critical illnes requiring volume resuscitation with fluids (e.g. Sepsis). | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005589-37 | Sponsor Protocol Number: RMRHS0095 | Start Date*: 2013-03-08 | ||||||||||||||||
Sponsor Name:University of Warwick | ||||||||||||||||||
Full Title: select-d: Anticoagulation Therapy in SELECTeD Cancer Patients at Risk of Recurrence of Venous Thromboembolism | ||||||||||||||||||
Medical condition: Venous Thromboembolism and Cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2022-000186-40 | Sponsor Protocol Number: B1931036 | Start Date*: 2022-10-07 | |||||||||||
Sponsor Name:Pfizer Inc. | |||||||||||||
Full Title: A PROSPECTIVE, RANDOMIZED, OPEN-LABEL PHASE 2 STUDY TO EVALUATE THE SUPERIORITY OF INOTUZUMAB OZOGAMICIN MONOTHERAPY VERSUS ALLR3 FOR INDUCTION TREATMENT OF CHILDHOOD HIGH RISK FIRST RELAPSE B-CELL... | |||||||||||||
Medical condition: Acute Lymphoblastic Leukemia (ALL) | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Ongoing) DE (Ongoing) AT (Ongoing) BE (Ongoing) SE (Ongoing) FR (Ongoing) SK (Ongoing) IT (Ongoing) ES (Ongoing) PL (Ongoing) GR (Ongoing) CZ (Ongoing) NL (Ongoing) FI (Ongoing) DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003200-23 | Sponsor Protocol Number: 2013DR3084 | Start Date*: 2016-04-21 |
Sponsor Name:University Hospital Basel; Neurology | ||
Full Title: Biomarkers and antithrombotic treatment in cervical artery dissection (TREAT-CAD) | ||
Medical condition: cervical artery dissection | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-001048-12 | Sponsor Protocol Number: GEIS40 | Start Date*: 2015-10-13 |
Sponsor Name:GEIS (Grupo Español de Investigación en Sarcomas) | ||
Full Title: Phase II, single arm, non-randomized and multicenter clinical trial of regorafenib as a single agent in the first-line setting for patients with metastatic and/or unresectable KIT/PDGFR Wild Type GIST | ||
Medical condition: KIT/PDGFR wild type GastroIntestinal Stromal Tumor (GIST) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-001910-25 | Sponsor Protocol Number: WIL-21 | Start Date*: 2008-07-17 | |||||||||||
Sponsor Name:Octapharma AG | |||||||||||||
Full Title: Pharmacokinetics of WILATE® and Haemate® P in von Willebrand type 3 patients - a prospective, randomised, controlled, open-labelled, 2-arm cross-over study | |||||||||||||
Medical condition: Inherited von Willebrand Disease (VWD) type 3 | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002285-21 | Sponsor Protocol Number: 1160.138 | Start Date*: 2011-12-20 | |||||||||||
Sponsor Name:Boehringer Ingelheim RCV GmbH & Co KG | |||||||||||||
Full Title: Evaluation of the long term safety of the use of dabigatran etexilate in patients with a bileaflet mechanical heart valve | |||||||||||||
Medical condition: Anticoagulation following mechanical heart valve surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) DK (Completed) NL (Completed) BE (Completed) DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004735-39 | Sponsor Protocol Number: M14NEC | Start Date*: 2015-11-10 |
Sponsor Name:NKI-AVL | ||
Full Title: Phase II Study of cisplatin and everolimus in patients with metastatic or unresectable neuroendocrine carcinomas (NEC) of extrapulmonary origin | ||
Medical condition: Patients with metastatic neuroendocrine carcinomas of extrapulmonary origin will be eligible | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-005524-13 | Sponsor Protocol Number: I-ICRNS-005-PRCLD-DVT-01 | Start Date*: 2006-03-22 | |||||||||||
Sponsor Name:CRINOS S.p.A. | |||||||||||||
Full Title: Defibrotide in the prevention of recurrences in venous thrombosis: DEPRIVE. A randomised, multicentre, European, double blind, parallel group study, to assess the efficacy and tolerability of defib... | |||||||||||||
Medical condition: DVT and PE are part of the same disease that can be defined Venous Thromboembolism (VTE). Treatment of the acute phases is well established: LMWH during the first days and OAT for 3-12 months. Afte... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004651-10 | Sponsor Protocol Number: Angio-Next-0710 | Start Date*: 2007-12-19 | |||||||||||
Sponsor Name:Centre Oscar Lambret | |||||||||||||
Full Title: Etude de phase II multicentrique stratifiée évaluant l’efficacité et la toxicité du Sorafenib dans le traitement des angiosarcomes localement avancés ou métastatiques non accessibles à une chirur... | |||||||||||||
Medical condition: ANGIOSARCOME LOCALEMENT AVANCE OU METASTATIQUE | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001529-15 | Sponsor Protocol Number: RATIOSTUDY | Start Date*: 2016-10-26 | |||||||||||
Sponsor Name:AZIENDA SOCIO-SANITARIA TERRITORIALE DI LECCO (ASST LECCO) | |||||||||||||
Full Title: Randomized Anticoagulation Trial In Opcab HIGH DOSE VERSUS LOW DOSE HEPARINIZATION IN PATIENTS | |||||||||||||
Medical condition: Off-pump coronary artery bypass grafting (OPCAB) is an established alternative to on-pump coronary artery bypass grafting (CABG), OPCAB, like any other surgical procedure, determines a pro-coagulan... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.